Trial · NCT00527787
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Gastric Ulcer Confirmed by Endoscopy | PN400 (VIMOVO) | 9 | 1.9 to 7.7 | Participants | |
| Number of Participants With Gastric Ulcer Confirmed by Endoscopy | Naproxen | 50 | 17.7 to 29.4 | Participants | |
| The Number of Participants With Pre-Specified NSAID-Associated Upper GI Adverse Events or Duodenal Ulcers | PN400 (VIMOVO) | 114 | 45.4 to 59.1 | Participants | |
| The Number of Participants With Pre-Specified NSAID-Associated Upper GI Adverse Events or Duodenal Ulcers | Naproxen | 149 | 62.4 to 75.1 | Participants | |
| The Number of Participants Discontinuing From the Study Due to NSAID-Associated Upper GI Adverse Events or to Duodenal Ulcer | PN400 (VIMOVO) | 7 | 1.3 to 6.5 | Participants | |
| The Number of Participants Discontinuing From the Study Due to NSAID-Associated Upper GI Adverse Events or to Duodenal Ulcer | Naproxen | 26 | 8.0 to 17.1 | Participants | |
| The Number of Participants Developing Duodenal Ulcers Throughout 6 Months of Treatment | PN400 (VIMOVO) | 1 | 0 to 2.5 | Participants | |
| The Number of Participants Developing Duodenal Ulcers Throughout 6 Months of Treatment | Naproxen | 11 | 2.6 to 8.9 | Participants | |
| Heartburn Symptom Resolution, ie no Heartburn Symptoms During the Last 7 Days Prior to the Visit | PN400 (VIMOVO) | 140 | participants | ||
| Heartburn Symptom Resolution, ie no Heartburn Symptoms During the Last 7 Days Prior to the Visit | Naproxen | 65 | participants | ||
| Improvement From Baseline in Upper Abdominal Pain and Discomfort Scores at 6 Months, Based on the Overall Treatment Evaluation for Dyspepsia Questionnaire | PN400 (VIMOVO) | 93 | Participants | ||
| Improvement From Baseline in Upper Abdominal Pain and Discomfort Scores at 6 Months, Based on the Overall Treatment Evaluation for Dyspepsia Questionnaire | Naproxen | 52 | Participants | ||
| Mean Change From Baseline on Pain Intensity of the Severity of Dyspepsia Assessment (SODA) Subscales | PN400 (VIMOVO) | -6 | Standard Error 0.7 | Units on SODA Subscale | |
| Mean Change From Baseline on Pain Intensity of the Severity of Dyspepsia Assessment (SODA) Subscales | Naproxen | 0 | Standard Error 0.7 | Units on SODA Subscale | |
| Mean Change From Baseline on Non-Pain Symptoms of the Severity of Dyspepsia Assessment (SODA) Subscales | PN400 (VIMOVO) | -2.2 | Standard Error 0.3 | Units on SODA Subscale | |
| Mean Change From Baseline on Non-Pain Symptoms of the Severity of Dyspepsia Assessment (SODA) Subscales | Naproxen | -0.5 | Standard Error 0.3 | Units on SODA Subscale | |
| Mean Change From Baseline on Satisfaction of the Severity of Dyspepsia Assessment (SODA) Subscales | PN400 (VIMOVO) | 3.4 | Standard Error 0.4 | Units on SODA Subscale | |
| Mean Change From Baseline on Satisfaction of the Severity of Dyspepsia Assessment (SODA) Subscales | Naproxen | 0.9 | Standard Error 0.4 | Units on SODA Subscale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00527787/results